Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Omnicell, Inc./ 10-K

Annual Report · 10-K

Omnicell, Inc.

OMCLNASDAQEQUITYCurrent

Annual Report

Filed Feb 27, 2025Accepted Feb 27, 2025, 4:27 PM ESTCIK 926326Accession 0000926326-25-000003
View company →Permanent SEC source ↗
Share

Company context

Since 1992, Omnicell has been committed to delivering innovative, outcomes-centric pharmacy and nursing solutions for all settings of care. As an intelligent medication management technology company, Omnicell empowers autonomous medication management by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that improve efficiency and enhance patient safety for healthcare facilities worldwide. Learn more at omnicell.com.

Current securities

OMCLNASDAQ · EQUITY · Current

Recent company filings

  1. 144 filingAug 17, 2026
  2. SCHEDULE 13G/A filingAug 10, 2026
  3. 10-Q filingAug 5, 2026
  4. Results of Operations and Financial ConditionJul 30, 2026
  5. 144 filingJul 15, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗